The SPECTRA Study
NCT00537667 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2009-11-26
Summary
The purpose of this study is to compare IL-1ra and the combination of IL-1ra and PEGsTNF-RI with respect to their ability to reduce inflammation and bone and cartilage destruction in the synovium of subjects with rheumatoid arthritis.
Conditions
Interventions
- DRUG
-
anakinra
anakinra
- DRUG
-
anakinra and PEG sTNF-R1
anakinra and PEG sTNF-R1
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-08-31
- Primary Completion
- 2003-03-31
- Completion
- 2003-06-30
More Related Trials
-
Safety and Efficacy of AMG 827 in Subjects With RA
NCT01059448 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
NCT02005757 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
NCT02260791 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
NCT00144508 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
NCT01606761 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
NCT00269867 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
NCT01526057 ·Status: COMPLETED ·Phase: PHASE2
-
Study of MRA in Patients With Rheumatoid Arthritis (RA)
NCT00144651 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
NCT00144573 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
NCT01927263 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
NCT00175877 ·Status: COMPLETED ·Phase: PHASE3
-
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT02889796 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP
NCT00144547 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
NCT00264537 ·Status: COMPLETED ·Phase: PHASE3
-
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
NCT01217086 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
NCT02046603 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP
NCT00144586 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
NCT02222493 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)
NCT01604343 ·Status: COMPLETED ·Phase: PHASE3
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
NCT01197066 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
NCT00160641 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis
NCT03161457 ·Status: TERMINATED ·Phase: PHASE1
-
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
NCT00339157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
NCT02886728 ·Status: COMPLETED ·Phase: PHASE3